Market Overview

UPDATE: JP Morgan Initiates LifePoint Hospitals at Overweight on Gains from Reform

Share:

JP Morgan initiated coverage on LifePoint Hospitals (NASDAQ: LPNT) with an Overweight rating and a $46 price target.

JP Morgan commented, "LifePoint should enjoy the highest EBITDA upside potential from reform-based coverage expansion. A combination of the company's geographic footprint, coupled with the managed care negotiating leverage of a sole community provider heading into exchange pricing discussions, should enable LifePoint to capture outsized gains compared to peers in our opinion. Our JP Morgan Healthcare Reform Model estimates that LifePoint has the potential to see ~13% EBITDA upside from reform relative to our baseline model, although a relative lack of financial leverage leaves relative EPS gains significant but more in line to peer average."

LifePoint Hospitals closed at $36.92 on Monday.

Latest Ratings for LPNT

DateFirmActionFromTo
Jul 2018MaintainsNeutralNeutral
Jul 2018MaintainsMarket PerformMarket Perform
Jul 2018DowngradesOutperformNeutral

View More Analyst Ratings for LPNT
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (LPNT)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
WUBADowngrades
DLTRUpgrades
ARCCDowngrades
GTYHInitiates Coverage On7.0
NKEMaintains100.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: JP Morgan Initiates HCA Holdings at Overweight on Reform Leverage

UPDATE: Citigroup Initiates Raymond James Financial at Buy on EPS, Margin Mix